Our team studies risk factors, genomics, biological models and cellular science to better understand the causes of heart disease and stroke.

We produce comprehensive, systematic reviews of important medical topics using interdisciplinary teams that integrate clinical expertise with expertise in evidence-based methods, including meta-analysis, decision analysis, benefit-harms analysis and cost-effectiveness analysis.

Our center serves as an academic bridge between the Johns Hopkins University School of Medicine and the Bloomberg School of Public Health to conduct clinical, epidemiologic and translational research of the highest quality.

Our center studies diseases of the heart and blood vessels, such as high blood pressure, coronary artery disease and diabetes.

Our team conducts multidisciplinary research on policies and practices, with a special focus on their impact on quality of care and patient-centered outcomes.

We seek to improve the safe and effective use of medications by bringing together researchers at Johns Hopkins to accomplish a fourfold mission — training, research, patient care and public service — toward best medication practices.

We aim to address a Baltimore epidemic by recruiting and developing a new generation of HIV/AIDS researchers.

Our center aims to empower health care providers and health researchers in resource-limited communities. The center’s partnerships currently span 20 countries.

We aim to apply medical technology to basic advances in understanding of the pathogenesis of TB, host immunity to TB, mechanisms of spread and animal models that better emulate the pathology of human disease.

We are dedicated to the clinical research of diseases that may be classified as environmental infectious diseases, includes disease-causing agents found in traditional ecological environments, such as air, soil and water, and those acquired from built environments.

Our program aims to expand institutional expertise in clinical and academic activities focused on infectious complications in transplant (solid organ and stem cell) and oncology patients at Johns Hopkins.

Our center has several extensive programs in basic research related to hepatitis B and hepatitis C infections.

Our mission is to develop and test the accuracy, acceptability, and optimal implementation of point-of-care tests for sexually transmitted diseases in diverse care delivery contexts both in the United States and in resource-limited settings.

We are leaders in the design of innovative interventions to promote adherence and the measurement and evaluation of adherence within clinical trials.

We are a multidisciplinary clinical and research group focused on understanding and improving patient outcomes after critical illness and surgery.